Table 1.

Clinical diagnoses of patients receiving meropenem

Diagnosis	N (%)a
Respiratory tract infection	41 (37.3)
bronchiectasis exacerbation	19 (17.3)
ventilator-associated pneumonia	9 (8.2)
hospital-acquired pneumonia	5 (4.5)
community-acquired pneumonia	4 (3.6)
cystic fibrosis exacerbation	4 (3.6)
Urinary tract infection	14 (12.7)
Intra-abdominal infection	12 (10.9)
Neutropenic sepsis	9 (8.2)
Post-neurosurgical CNS infection	6 (5.5)
Non-infectious diagnosisb	6 (5.5)
Other infectionc	8 (7.3)
CNS infection	4 (3.6)
Surgical site infection	4 (3.6)
Bacteraemia, unknown source	2 (1.8)
Osteomyelitis	2 (1.8)
Skin and soft tissue infection	2 (1.8)

^a n = 110 diagnoses as some patients had >1 diagnosis.

^bMethotrexate pneumonitis (n = 1); ischaemic bowel (n = 1); fever due to cancer (n = 3); and unknown but infection not proven (n = 1).

^cLine infection (n = 5); sepsis from unknown source (n = 1); infected spinal metalwork (n = 1); empyema and sub-phrenic collections (n = 1).